BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 35687813)

  • 1. Barriers and Facilitators to HIV Pre-Exposure Prophylaxis Uptake, Adherence, and Persistence Among Transgender Populations in the United States: A Systematic Review.
    Dang M; Scheim AI; Teti M; Quinn KG; Zarwell M; Petroll AE; Horvath KJ; John SA
    AIDS Patient Care STDS; 2022 Jun; 36(6):236-248. PubMed ID: 35687813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Access to Pre-Exposure Prophylaxis Among Transgender Women and Transfeminine Nonbinary Individuals.
    Klein A; Golub SA
    AIDS Patient Care STDS; 2019 Jun; 33(6):262-269. PubMed ID: 31166785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitators of PrEP Persistence among Black and Latinx Transgender Women in a PrEP Demonstration Project in Southern California.
    Storholm ED; Ogunbajo A; Nacht CL; Opalo C; Horvath KJ; Lyman P; Flynn R; Reback CJ; Blumenthal J; Moore DJ; Bolan R; Morris S
    Behav Med; 2024; 50(1):63-74. PubMed ID: 35993278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California.
    Watson CW; Pasipanodya E; Savin MJ; Ellorin EE; Corado KC; Flynn RP; Opalo C; Lampley E; Henry BL; Blumenthal J; Bolan R; Morris S; Moore DJ
    AIDS Educ Prev; 2020 Dec; 32(6):472-485. PubMed ID: 33779208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caring for the whole person: transgender-competent HIV pre-exposure prophylaxis as part of integrated primary healthcare services in Vietnam.
    Doan AH; Vu CMH; Nguyen TT; Green KE; Phan HTT; Janamnuaysook R; Vu BN; Le TM; Do KQ; Tran TT; Ngo TM; Basu L; Tran LK; Humeau Z
    J Int AIDS Soc; 2022 Oct; 25 Suppl 5(Suppl 5):e25996. PubMed ID: 36225133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of Pre-exposure Prophylaxis (PrEP) Implementation in Transgender Populations: A Qualitative Scoping Review.
    Zamantakis A; Li DH; Benbow N; Smith JD; Mustanski B
    AIDS Behav; 2023 May; 27(5):1600-1618. PubMed ID: 36520334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study.
    Janamnuaysook R; Guo Y; Yu YJ; Phanuphak N; Kawichai S; MacDonell K; Jupimai T; Rongkavilit C; Wang B
    Sex Health; 2024 Jan; 21():. PubMed ID: 38219741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to uptake of PrEP across the continuum among transgender women: A global scoping review.
    Teng F; Sha Y; Fletcher LM; Welsch M; Burns P; Tang W
    Int J STD AIDS; 2023 Apr; 34(5):299-314. PubMed ID: 36793197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Some of us, we don't know where we're going to be tomorrow." Contextual factors affecting PrEP use and adherence among a diverse sample of transgender women in San Francisco.
    Cahill SR; Keatley J; Wade Taylor S; Sevelius J; Elsesser SA; Geffen SR; Wang T; Mayer KH
    AIDS Care; 2020 May; 32(5):585-593. PubMed ID: 31482726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence and implication of interventions across various socioecological levels to address pre-exposure prophylaxis uptake and adherence among men who have sex with men in the United States: a systematic review.
    Wang Y; Mitchell JW; Zhang C; Liu Y
    AIDS Res Ther; 2022 Jun; 19(1):28. PubMed ID: 35754038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dismantling Barriers and Transforming the Future of Pre-Exposure Prophylaxis Uptake in Young Black and Latinx Sexual Minority Men and Transgender Women.
    Shorrock F; Alvarenga A; Hailey-Fair K; Vickroy W; Cos T; Kwait J; Trexler C; Wirtz AL; Galai N; Beyrer C; Celentano D; Arrington-Sanders R
    AIDS Patient Care STDS; 2022 May; 36(5):194-203. PubMed ID: 35507322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    Malone J; Reisner SL; Cooney EE; Poteat T; Cannon CM; Schneider JS; Radix A; Mayer KH; Haw JS; Althoff KN; Wawrzyniak AJ; Beyrer C; Wirtz AL;
    J Acquir Immune Defic Syndr; 2021 Sep; 88(1):10-18. PubMed ID: 34397742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PrEP for women in Europe: a systematic literature review.
    Fitzgerald N; Coltart H; Dominguez L; Flanagan K; Gilleece Y
    HIV Med; 2023 Jul; 24(7):765-776. PubMed ID: 37088558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of PrEP among transgender women: the critical role of gender affirmation in research and clinical practices.
    Sevelius JM; Deutsch MB; Grant R
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21105. PubMed ID: 27760683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
    Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
    J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake, Retention, and Adherence to Pre-exposure Prophylaxis (PrEP) in TRIUMPH: A Peer-Led PrEP Demonstration Project for Transgender Communities in Oakland and Sacramento, California.
    Sevelius JM; Glidden DV; Deutsch M; Welborn L; Contreras A; Salinas A; Venegas L; Grant RM
    J Acquir Immune Defic Syndr; 2021 Dec; 88(S1):S27-S38. PubMed ID: 34757990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations for the Design of Pre-exposure Prophylaxis (PrEP) Interventions for Women: Lessons Learned from the Implementation of a Novel PrEP Intervention.
    Walters SM; Platt J; Anakaraonye A; Golub SA; Cunningham CO; Norton BL; Sevelius JM; Blackstock OJ
    AIDS Behav; 2021 Dec; 25(12):3987-3999. PubMed ID: 34138377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California.
    Ogunbajo A; Storholm ED; Ober AJ; Bogart LM; Reback CJ; Flynn R; Lyman P; Morris S
    AIDS Behav; 2021 Jul; 25(7):2301-2315. PubMed ID: 33515132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of Online Posts to Identify Barriers to and Facilitators of HIV Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men: A Comparison to a Systematic Review of the Peer-Reviewed Literature.
    Hannaford A; Lipshie-Williams M; Starrels JL; Arnsten JH; Rizzuto J; Cohen P; Jacobs D; Patel VV
    AIDS Behav; 2018 Apr; 22(4):1080-1095. PubMed ID: 29285638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender-Based Violence and Post-traumatic Stress Disorder Symptoms Predict HIV PrEP Uptake and Persistence Failure Among Transgender and Non-binary Persons Participating in a PrEP Demonstration Project in Southern California.
    Storholm ED; Huang W; Ogunbajo A; Horvath KJ; Reback CJ; Blumenthal J; Moore DJ; Flynn RP; Bolan RK; Corado KC; Morris SR
    AIDS Behav; 2023 Feb; 27(2):745-759. PubMed ID: 36053404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.